Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Mitchell Dean J, Director. Officer active across 4 companies, notably ImmunoGen, Inc.. In total, 18 disclosures have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €114k. History available since 3 September 2021. The latest transaction was disclosed on 24 September 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Mitchell Dean J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5,000 shares@ US$1.845.3% of flowCommon StockSEC:0001179110-21-008587:0
18 of 18 declarations
About Mitchell Dean J
MITCHELL DEAN J is Administrateur and has filed 18 reports between 2021-09-03 and 2025-09-25. Across the 18 sampled filings, buys total 113817 EUR and sells total 0 EUR, with Levée d'options as the most frequent transaction nature.